InVivium Capital

InVivium Capital

Signal active

Investment Firm

Overview

N/A

Highlights

Founded

Invalid date

Industry

Venture Capital

Employees

1-10

Investment

2

Lead Investment

1

Exits

1

Stages

Late Stage Venture

Investor Type

Venture Capital

Location

United States, North America

Contact Information

Social

Profile Resume

InVivium Capital, established in Unknown year and headquartered in United States, North America., specializes in Late Stage Venture investments across Biotechnology, Artificial Intelligence (AI), Biopharma, Neuroscience, Precision Medicine, Financial Services, Professional Services, Wealth Management, Hedge Funds, Enterprise Software. The organization boasts a portfolio of 2 investments, with an average round size of $37.5M and 1 successful exits. Their recent investments include Alto Neuroscience, Franklin Templeton, Point72 Ventures, Eli Lilly, Windham Venture Partners. The highest investment round they participated in was $9.1B. Among their most notable exits are Alto Neuroscience and Franklin Templeton. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

N/A

Investment portfolio

InVivium Capital has made 2 investments. Their most recent investment was on Nov 21, 2023, when Alto Neuroscience raised $45.0M.

investments

2

Diversity investments

0

Lead investments

1

Number of exits

1

Investments

2

Annouced DateOrganization NameIndustryMoney Raised
Sep 19, 2023
Virtual Incision Virtual Incision
Health Care30.0M
Nov 21, 2023
Alto Neuroscience Alto Neuroscience
Biotechnology45.0M

Exits

1

Funding Timeline

Funding rounds

2

Investors

0

Funds

0

Funding Rounds

2

InVivium Capital has raised 2 rounds. Their latest funding was raised on Nov 21, 2023 from a Series C - Alto Neuroscience round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Sep 19, 2023
Series C - Virtual Incision Series C - Virtual Incision
-30.0M-
Nov 21, 2023
Series C - Alto Neuroscience Series C - Alto Neuroscience
-45.0M-

Investors

0

There is no funding round available on this profile

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries

Recent Activity

There is no recent news or activity for this profile.